Tenoxicam

Major

Tenoxicam Fluorouracil Topical Carac Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Tenoxicam Flurbiprofen Ansaid Increased risk of bleeding Details Tenoxicam Flurbiprofen Ophthalmic Ocufen Increased risk of bleeding Details Tenoxicam Fondaparinux Arixtra An increased risk of bleeding Details Tenoxicam Fondaparinux Injection Arixtra An increased risk of bleeding Details Tenoxicam Furosemide Injection Disal Reduced diuretic effectiveness and possible nephrotoxicity Details Tenoxicam Heparin An increased risk of bleeding Details Tenoxicam Heparin Injection Lipo-Hepin® An increased risk of bleeding Details Tenoxicam Hydrocortisone Ala-Cort Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Hydrocortisone Injection A-Hydrocort® Increased risk of gastrointestinal ulcer or bleeding Details Tenoxicam Ibuprofen Addaprin An increased risk of gastrointestinal toxicity Details Tenoxicam Iloprost Aurlumyn An increased risk of bleeding Details Tenoxicam Ketoprofen Actron® Increased risk of bleeding Details Tenoxicam Lithium Carbonate Lithobid Increased lithium exposure and an increased risk of lithium toxicity Details Tenoxicam Meclofenamate Meclodium® Increased risk of bleeding Details Tenoxicam Mefenamic Acid Ponstel® Increased risk of bleeding Details Tenoxicam Meloxicam Alloxate An increased risk of gastrointestinal toxicity and an increased risk of bleeding Details Tenoxicam Meloxicam Injection Alloxate An increased risk of gastrointestinal toxicity and an increased risk of bleeding Details Tenoxicam Melphalan Alkeran An increased risk of bleeding Details Tenoxicam Melphalan Injection Alkeran An increased risk of bleeding Details Tenoxicam Mesalamine Apriso Increased risk of bleeding Details Tenoxicam Mesalamine Rectal Canasa Increased risk of bleeding Details Tenoxicam Methotrexate Jylamvo Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Tenoxicam Methotrexate Injection Abitrexate® Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Tenoxicam Nabumetone Relafen Increased risk of bleeding Details Tenoxicam Naproxen Aleve Increased risk of bleeding Details Tenoxicam Pemetrexed Injection Alimta Increased PEMEtrexed exposure and an increased risk of PEMEtrexed toxicity (myelosuppression, renal toxicity, and gastrointestinal... Details

Moderate

Tenoxicam Lisinopril Prinivil Explained Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Tenoxicam Atenolol Tenormin Explained Reduced antihypertensive effect Details Tenoxicam Acebutolol Sectral® Reduced antihypertensive effect Details Tenoxicam Benazepril Lotensin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Tenoxicam Azilsartan Edarbi Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Tenoxicam Betaxolol Betoptic S Reduced antihypertensive effect Details Tenoxicam Betaxolol Ophthalmic Betoptic® Reduced antihypertensive effect Details Tenoxicam Bisoprolol Zebeta® Reduced antihypertensive effect Details Tenoxicam Captopril Capoten® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Tenoxicam Desmopressin Nasal Concentraid® Increased risk of water intoxication with hyponatremia Details Tenoxicam Enalapril Epaned Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Tenoxicam Eprosartan Teveten® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Tenoxicam Esmolol Brevibloc Reduced antihypertensive effect Details